LONDON, Nov 23 (Reuters) - Britain's AstraZeneca said on
Monday its vaccine for the novel coronavirus could be around 90%
effective without any serious side effects, the latest drugmaker
to unveil positive interim data in a scientific race to curb a
global pandemic.
Below are highlights from a press conference given by
AstraZeneca and Oxford University following the release of the
trial results of their vaccine.
PASCAL SORIOT, CEO OF ASTRAZENECA
"Being able to vaccinate more people faster is a really a
big plus."
ANDREW POLLARD, DIRECTOR OF THE OXFORD VACCINE GROUP
"This means we have a vaccine for the world.
"It prevents severe disease and hospitalisation.
"This is an incredibly exciting moment for human health."
(Reporting by Kate Kelland)